Pharmacies and hospitals looking to streamline the manual process of compounding personalized medicines just got a boost, as healthtech firm CurifyLabs announced it has secured $14.0M in Series A funding. The round was led by Sandwater and HealthCap, with additional investment from Tesi, Finnish Industry Investment Ltd, and Lifeline Ventures.
CurifyLabs, founded in 2021, is behind the Compounding System Solution (CSS), an automated platform for non-sterile compounding. The system integrates GMP-manufactured excipient bases, 3D printing-inspired robotics, in-process quality control, and a formulation library to ensure consistent quality and improved efficiency. CSS is currently in clinical use with customers in Europe and the US.















